Prognostic stratification in non-small cell lung cancer using a TIDE-informed transcriptomic signature: model development and validation
{{output}}
Background: Non-small cell lung cancer (NSCLC) remains a major cause of cancer mortality. The Tumor Immune Dysfunction and Exclusion (TIDE) score is widely used to estimate immune-checkpoint blockade response, but its broader pro... ...
